BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21504569)

  • 1. Ageing and smoking contribute to plasma surfactant proteins and protease imbalance with correlations to airway obstruction.
    Ilumets H; Mazur W; Toljamo T; Louhelainen N; Nieminen P; Kobayashi H; Ishikawa N; Kinnula VL
    BMC Pulm Med; 2011 Apr; 11():19. PubMed ID: 21504569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects.
    Beeh KM; Beier J; Kornmann O; Buhl R
    Respir Med; 2003 Jun; 97(6):634-9. PubMed ID: 12814147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationships between the expressions of intercellular adhesion molecule-1 and tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 in lung tissues of patients with chronic obstructive pulmonary disease].
    Kong YJ; Sun WX; Zhang YM; Shi YZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Feb; 31(2):129-33. PubMed ID: 18683786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
    Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio in smokers with airway hyperresponsiveness and accelerated lung function decline.
    Lo CY; Huang HY; He JR; Huang TT; Heh CC; Sheng TF; Chung KF; Kuo HP; Wang CH
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1135-1144. PubMed ID: 29692608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD.
    Winkler C; Atochina-Vasserman EN; Holz O; Beers MF; Erpenbeck VJ; Krug N; Roepcke S; Lauer G; Elmlinger M; Hohlfeld JM
    Respir Res; 2011 Mar; 12(1):29. PubMed ID: 21396106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum surfactant protein-A, but not surfactant protein-D or KL-6, can predict preclinical lung damage induced by smoking.
    Kobayashi H; Kanoh S; Motoyoshi K
    Biomarkers; 2008 Jun; 13(4):385-92. PubMed ID: 18595202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung matrix metalloproteinase-9 correlates with cigarette smoking and obstruction of airflow.
    Kang MJ; Oh YM; Lee JC; Kim DG; Park MJ; Lee MG; Hyun IG; Han SK; Shim YS; Jung KS
    J Korean Med Sci; 2003 Dec; 18(6):821-7. PubMed ID: 14676438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma.
    Culpitt SV; Rogers DF; Traves SL; Barnes PJ; Donnelly LE
    Respir Med; 2005 Jun; 99(6):703-10. PubMed ID: 15878486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of correlation between pulmonary function and expression levels of matrix metalloproteinases-9 and tissue inhibitor of metalloproteinase-1 among toluene diisocyanate exposed workers].
    Miao PP; Meng T; Jia Q; Niu Y; Ye M; Ji YQ; Ju R; Chen XL; Shao H; Zheng YX; Dai YF
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 May; 50(5):418-22. PubMed ID: 27141897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADAM15 expression is increased in lung CD8
    Wang X; Zhang D; Higham A; Wolosianka S; Gai X; Zhou L; Petersen H; Pinto-Plata V; Divo M; Silverman EK; Celli B; Singh D; Sun Y; Owen CA
    Respir Res; 2020 Jul; 21(1):188. PubMed ID: 32677970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of surfactant proteins A and D and KL-6 are elevated in the induced sputum of chronic obstructive pulmonary disease patients: a sequential sputum analysis.
    Ishikawa N; Hattori N; Tanaka S; Horimasu Y; Haruta Y; Yokoyama A; Kohno N; Kinnula VL
    Respiration; 2011; 82(1):10-8. PubMed ID: 21474912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship Between Circulating Serpina3g, Matrix Metalloproteinase-9, and Tissue Inhibitor of Metalloproteinase-1 and -2 with Chronic Obstructive Pulmonary Disease Severity.
    Uysal P; Uzun H
    Biomolecules; 2019 Feb; 9(2):. PubMed ID: 30781876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum metalloproteinase-9 is related to COPD severity and symptoms - cross-sectional data from a population based cohort-study.
    Linder R; Rönmark E; Pourazar J; Behndig A; Blomberg A; Lindberg A
    Respir Res; 2015 Feb; 16(1):28. PubMed ID: 25849664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of shuxuening injection on the levels of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in acute exacerbated chronic obstructive pulmonary disease patients].
    Wang TJ; Xie ZH; Zhao ZZ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Feb; 32(2):191-4. PubMed ID: 22574591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentration of matrix metalloproteinase-9 in serum of patients with chronic obstructive pulmonary disease and a degree of airway obstruction and disease progression.
    Brajer B; Batura-Gabryel H; Nowicka A; Kuznar-Kaminska B; Szczepanik A
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():145-52. PubMed ID: 19218638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking reduces surfactant protein D and phospholipids in patients with and without chronic obstructive pulmonary disease.
    Moré JM; Voelker DR; Silveira LJ; Edwards MG; Chan ED; Bowler RP
    BMC Pulm Med; 2010 Oct; 10():53. PubMed ID: 20973980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of patients with chronic obstructive pulmonary disease (COPD) by measurement of plasma biomarkers.
    Shaker SB; von Wachenfeldt KA; Larsson S; Mile I; Persdotter S; Dahlbäck M; Broberg P; Stoel B; Bach KS; Hestad M; Fehniger TE; Dirksen A
    Clin Respir J; 2008 Jan; 2(1):17-25. PubMed ID: 20298300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population.
    Guo X; Lin HM; Lin Z; Montaño M; Sansores R; Wang G; DiAngelo S; Pardo A; Selman M; Floros J
    Eur Respir J; 2001 Sep; 18(3):482-90. PubMed ID: 11589345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liuweibuqi capsules improve pulmonary function in stable chronic obstructive pulmonary disease with lung-qi deficiency syndrome by regulating STAT4/STAT6 and MMP-9/TIMP-1.
    Shen DD; Yang ZH; Huang J; Yang F; Lin ZW; Ou YF; Hu MH
    Pharm Biol; 2019 Dec; 57(1):744-752. PubMed ID: 31679431
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.